Clinical trials
We can help you progress healthcare innovations through clinical trials and into clinical use.
Whether it’s a therapy, diagnostic, device or other medical technology, we can help you navigate the clinical development journey and increase the likelihood of reaching patients.
Our experienced clinical team offers personalised development strategies and planning to support you across all aspects of clinical affairs, including trial design and operations, regulatory compliance, and stakeholder engagement with patients and healthcare professionals.
Our areas of expertise
Clinical trial design, set up and management.
Clinical operations and global logistics.
Experience in diagnostic and therapeutic development.
Patient and healthcare professional engagement, clinical pathway mapping, target product profile (TPP) development.
Clinical trials we’re supporting
Research area
Indication
Intervention
Trial Phase
-
Research area:
Chronic respiratory infectionDisease:
Intervention:
Phase:
ASM in CF: ANNE Sensor Monitoring in Cystic Fibrosis
-
Research area:
Chronic respiratory infectionDisease:
Intervention:
Phase:
Bronch-EX: Early Detection of Pulmonary Exacerbations in Non-cystic Fibrosis Bronchiectasis
-
Research area:
Chronic respiratory infectionDisease:
Intervention:
Phase:
EMBARC-AIRNET: The EMBARC Anti-Inflammatory Repurposing Network
-
Research area:
Rare diseaseDisease:
Intervention:
Phase:
FARGO: FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis
-
Research area:
Rare diseaseDisease:
Intervention:
Phase:
Gene Therapy with Modified Autologous Hematopoietic Stem Cells for Patients with Mucopolysaccharidosis Type II
-
Research area:
Rare diseaseDisease:
Intervention:
Phase:
DefINe: A trial to test the use of deferiprone in people with neuroferritinopathy
-
Research area:
Motor neuron diseaseDisease:
Intervention:
Phase:
EXPERTS-ALS: EXPErimental medicine Route To Success in Amyotrophic Lateral Sclerosis
-
Research area:
Global healthDisease:
Intervention:
Phase:
TIME study: TB DIagnosis and Monitoring Evaluation
-
Research area:
Rare diseaseDisease:
Intervention:
Phase:
TIARA: Autologous Tregs for Aplastic Anaemia
-
Research area:
Rare diseaseDisease:
Intervention:
Phase:
Prospective evaluation of KARSARC -a gene expression-based risk classifier for patients with soft tissue sarcomas treated with pazopanib
-
Research area:
Rare diseaseDisease:
Intervention:
Phase:
CADET trial
-
Research area:
Rare diseaseDisease:
Intervention:
Phase:
STOPFOP: Saracatinib Trial TO Prevent FOP
-
Research area:
Rare diseaseDisease:
Intervention:
Phase:
PKAN: Phase II Study of a Novel Vitamin Metabolite (CoA-Z) for Pantothenate Kinase Associated Neurodegeneration
*N/A is used for clinical trials which do not fit into the defined interventional trial phases. For example, those which are assessing the clinical performance of diagnostic devices or observational studies.
Unfortunately, we are not in a position to directly recruit people onto clinical trials. Please ask your doctor or a patient organisation if they know of any clinical trials that you may be eligible to join.
Other ways we can support you
Antibody discovery
Innovative single B-cell technologies and clinically-validated platform to generate fully human therapeutic antibodies.
Diagnostics development
We support all stages of diagnostic development, from assay design through to clinical validation.
Targeted protein degradation
PROTACs and alternative E3 ligases to degrade target proteins that aren’t classically targetable by small molecule inhibitors.
Commercialisation advice
Support your technology transfer to progress your work towards commercially viable products.
Who to contact
-
Jonathan Morgan
Read bio: Jonathan Morgan
-
Sara Brightwell-Muir
Read bio: Sara Brightwell-Muir